[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

IBEX Ltd reports a proposed sale of 14,523 shares of Common Stock tied to the vesting of a PSU grant on 09/30/2025. The filing lists this sale under equity compensation and notes recent open-market dispositions by Robert Thomas Dechant of 6,000 shares on each of several dates in February 2026.

The notice identifies J.P. Morgan Securities LLC as the broker and classifies the shares as Common Stock to be sold on Nasdaq. The filing is a routine regulatory notice of intended resale following equity compensation vesting.

Insights

Equity Capital Markets Analyst

Routine resale notice for vested compensation, not a corporate action.

The filing lists a proposed resale of 14,523 shares tied to a PSU vesting event dated 09/30/2025, and identifies J.P. Morgan Securities LLC as broker. This form notifies the market of an intended sale rather than a company capital-raising.

Cash-flow treatment is not detailed in the excerpt; subsequent transaction volumes and timing will depend on holder decisions and broker execution. Future SEC filings or Form 4/Form 5 entries could provide completed-sale detail.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	7800	237896.81	13405520	05/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Vesting of PSU Grant	IBEX Ltd (Issuer)			14523	09/30/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Thomas Dechant 1717 Pennsylvania Avenue, NW Suite 825 Washington DC 20006	Common	02/17/2026	6000	177784.96
Robert Thomas Dechant 1717 Pennsylvania Avenue, NW Suite 825 Washington DC 20006	Common	02/18/2026	6000	179853.76
Robert Thomas Dechant 1717 Pennsylvania Avenue, NW Suite 825 Washington DC 20006	Common	02/19/2026	6000	178358.29
Robert Thomas Dechant 1717 Pennsylvania Avenue, NW Suite 825 Washington DC 20006	Common	02/20/2026	6000	176398.24
Robert Thomas Dechant 1717 Pennsylvania Avenue, NW Suite 825 Washington DC 20006	Common	02/23/2026	6000	170752.63

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)